GERON CORP (GERN) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
GERN currently has 642M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 4.52% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 06, 2026 |
10-Q filing | 641.5M shares outstanding |
640M | 0 |
| Nov 07, 2025 |
10-Q filing | 667.1M shares outstanding |
670M | 0 |
| Aug 06, 2025 |
10-Q filing | 666.2M shares outstanding |
670M | 0 |
| May 07, 2025 |
10-Q filing | 665.9M shares outstanding |
670M | 0 |
| Feb 27, 2025 |
10-K filing | 646.0M shares outstanding |
650M | 0 |
| Nov 07, 2024 |
10-Q filing | 662.2M shares outstanding |
660M | 0 |
| Aug 08, 2024 |
10-Q filing | 653.9M shares outstanding |
650M | 0 |
| May 02, 2024 |
10-Q filing | 603.5M shares outstanding |
600M | 0 |
| Mar 20, 2024 |
8-K filing: Geron Corporation entered into an underwriting agreement for the issuance and sale of 41,999,998 shares of common stock at $3.00 per share and pre-funded warrants to purchase 8,002,668 shares of common stock at $2.999 per warrant, with gross proceeds expected to be approximately $150.0 million before deducting underwriting discounts and estimated offering expenses. |
570M | 0 |
| Feb 28, 2024 |
10-K filing | 570.6M shares outstanding |
570M | 0 |
| Nov 02, 2023 |
10-Q filing | 579.5M shares outstanding |
580M | 0 |
| Aug 03, 2023 |
10-Q filing | 547.3M shares outstanding |
550M | 0 |
| May 11, 2023 |
10-Q filing | 544.5M shares outstanding |
540M | 0 |
| Mar 16, 2023 |
10-K filing | 508.7M shares outstanding |
510M | 0 |
| Jan 06, 2023 |
8-K filing: Geron Corporation entered into an underwriting agreement with Goldman Sachs & Co. LLC for the issuance and sale of 55,876,297 shares of common stock and pre-funded warrants to purchase 25,000,000 shares of common stock, with an option for the underwriters to purchase an additional 12,131,444 shares, at a price of $2.45 per share and $2.449 per pre-funded warrant, expected to close on January 10, 2023, with gross proceeds expected to be $198.1 million. ($0.0M proceeds) |
410M | 0 |
| Nov 07, 2022 |
10-Q filing | 405.2M shares outstanding |
410M | 0 |
| Aug 11, 2022 |
10-Q filing | 403.9M shares outstanding |
400M | 0 |
| May 09, 2022 |
10-Q filing | 377.4M shares outstanding |
380M | 0 |
| Mar 30, 2022 |
8-K filing: Geron Corporation entered into an underwriting agreement for the issuance and sale of 53,333,334 shares of common stock and pre-funded warrants to purchase 18,095,238 shares of common stock, together with accompanying warrants to purchase 35,714,286 shares of common stock, with expected gross proceeds of approximately $75.0 million. ($74.98M proceeds) |
320M | 0 |
| Mar 10, 2022 |
10-K filing | 323.7M shares outstanding |
320M | 0 |
| Nov 09, 2021 |
10-Q filing | 321.9M shares outstanding |
320M | 0 |
| Aug 16, 2021 |
10-Q filing | 320.6M shares outstanding |
320M | 0 |
| May 10, 2021 |
10-Q filing | 318.6M shares outstanding |
320M | 0 |
| Mar 11, 2021 |
10-K filing | 318.5M shares outstanding |
320M | 0 |
| Nov 05, 2020 |
10-Q filing | 310.5M shares outstanding |
310M | 0 |
| Sep 04, 2020 |
S-3 filing: Geron Corporation files an S-3 registration statement to offer and sell up to $350,000,000 of any combination of common stock, preferred stock, debt securities and/or warrants, and registers an at-the-market offering to sell shares of its common stock through B. Riley FBR with an aggregate offering price of up to $100 million. |
310M | 0 |
| Aug 06, 2020 |
10-Q filing | 310.5M shares outstanding |
310M | 0 |
| May 28, 2020 |
10-Q filing | 203.3M shares outstanding |
200M | 0 |
| May 26, 2020 |
8-K filing: Geron Corporation entered into an underwriting agreement for the issuance and sale of 107,049,375 shares of common stock and pre-funded warrants to purchase 8,335,239 shares of common stock, along with warrants to purchase 57,692,307 shares of common stock, with an expected closing on May 27, 2020, and gross proceeds of approximately $150 million before deducting underwriting discounts and estimated offering expenses. ($150.0M proceeds) |
200M | 0 |
| Mar 12, 2020 |
10-K filing | 200.3M shares outstanding |
200M | 0 |